GLP ‐1(9‐37) Improves Left Ventricular Function in a Murine Model of Cardiac Pressure Overload by Promoting Mitochondrial Biogenesis

AIM: Glucagon-like peptide-1 (GLP-1) is an incretin hormone that is released in response to nutrient intake and inflammation. Its active form, GLP-1(7-37), binds to the GLP-1 receptor (GLP-1R), but GLP-1 is rapidly degraded by dipeptidyl peptidase-4 (DPP-4) into GLP-1(9-37), which does not bind to the classical GLP-1R. Both peptides exhibit cardioprotective effects, although the underlying mechanisms are unclear and the role of GLP-1(9-37) remains poorly understood. METHODS AND RESULTS: In this study, we investigated cardiac and metabolic effects of GLP-1(9-37) in a mouse model of cardiac pressure overload. LacZ and GLP-1(9-37) were overexpressed using an AAV vector system. While GLP-1(9-37) does not affect glucose metabolism, it mechanistically activates key metabolic regulators, as evidenced by increased AMPK and PGC1α signalling. This shift suggests an improvement in cellular energy balance and mitochondrial function under hypertrophic stress conditions. GLP-1(9-37) was also found to mitigate adverse cardiac remodelling. Treatment is associated with reduced septal thickness and decreased cardiac fibrosis, indicating attenuation of structural hypertrophy. CONCLUSIONS: In summary, our data suggest a protective role of GLP-1(9-37) in pressure-overload-induced cardiac remodelling, which is associated with AMPK/PGC1α-signalling.

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2026-11-16
DOI
https://doi.org/10.1111/dom.71541
Primary Topic
Cardiac Fibrosis and Remodeling
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

GLP ‐1(9‐37) Improves Left Ventricular Function in a Murine Model of Cardiac Pressure Overload by Promoting Mitochondrial Biogenesis

Corinna Lebherz, Nikolaus Marx, Julia Möllmann, Sanne Lidewij Maas et al.
1 links
Diabetes Obesity and Metabolism
Cardiac Fibrosis and Remodeling
article

GLP ‐1(9‐37) Improves Left Ventricular Function in a Murine Model of Cardiac Pressure Overload by Promoting Mitochondrial Biogenesis

Corinna Lebherz, Nikolaus Marx, Julia Möllmann, Sanne Lidewij Maas, Michael Lehrke, Robert Stöhr, Emiel P. C. van der Vorst, Oliver Winz, Felix M. Mottaghy
article en

Abstract

AIM: Glucagon-like peptide-1 (GLP-1) is an incretin hormone that is released in response to nutrient intake and inflammation. Its active form, GLP-1(7-37), binds to the GLP-1 receptor (GLP-1R), but GLP-1 is rapidly degraded by dipeptidyl peptidase-4 (DPP-4) into GLP-1(9-37), which does not bind to the classical GLP-1R. Both peptides exhibit cardioprotective effects, although the underlying mechanisms are unclear and the role of GLP-1(9-37) remains poorly understood. METHODS AND RESULTS: In this study, we investigated cardiac and metabolic effects of GLP-1(9-37) in a mouse model of cardiac pressure overload. LacZ and GLP-1(9-37) were overexpressed using an AAV vector system. While GLP-1(9-37) does not affect glucose metabolism, it mechanistically activates key metabolic regulators, as evidenced by increased AMPK and PGC1α signalling. This shift suggests an improvement in cellular energy balance and mitochondrial function under hypertrophic stress conditions. GLP-1(9-37) was also found to mitigate adverse cardiac remodelling. Treatment is associated with reduced septal thickness and decreased cardiac fibrosis, indicating attenuation of structural hypertrophy. CONCLUSIONS: In summary, our data suggest a protective role of GLP-1(9-37) in pressure-overload-induced cardiac remodelling, which is associated with AMPK/PGC1α-signalling.

Diabetes Obesity and Metabolism
Forschungszentrum Jülich (DE), Maastricht University Medical Centre (NL), Maastricht University (NL), Kreisklinik Trostberg (DE), Universitätsklinikum Aachen (DE), University Hospital Frankfurt (DE), Jülich Aachen Research Alliance (DE), Ludwig-Maximilians-Universität München (DE), RWTH Aachen University (DE)
Deutsche Forschungsgemeinschaft, Ernst und Berta Grimmke Stiftung
Good health and well-being
Cardiac Fibrosis and Remodeling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon